Bank­rupt Phase­Bio set­tles with in­vestor-part­ner, hand­ing off late-stage drug

SFJ Phar­ma­ceu­ti­cals is de­clar­ing the fi­nal vic­to­ry in its le­gal tus­sle with Phase­Bio over a blood thin­ner re­ver­sal agent.

Backed by Abing­worth and Black­stone, San …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER